摘要
目的评估2022年3月在我国大陆地区发生或者可能由境外输入的突发公共卫生事件风险。方法根据国内外突发公共卫生事件报告及重点传染病监测等各种资料和部门通报信息,采用专家会商法,并通过视频会议形式邀请省(自治区、直辖市)疾病预防控制中心专家参与评估。结果预计2022年3月突发公共卫生事件报告数可能将较2月有所上升。因境外新型冠状病毒肺炎(新冠肺炎)疫情输入导致本土疫情发生及传播扩散风险很高,在冬奥会和两会的背景下,新冠肺炎防控面临更大压力,各地需要按照国家要求加强疫情防控工作;根据往年诺如病毒病、布鲁氏菌病(布病)、发热伴血小板减少综合征报告趋势,预计3月仍持续高发。结论特别关注新冠肺炎,一般关注诺如病毒病、布病、发热伴血小板减少综合征。
Objective To assess the risk of public health emergencies,both the indigenous ones and the imported ones,which might occur in the mainland of China in March 2022.Methods An internet based expert counsel was conducted to analyze the surveillance data of public health emergencies and priority communicable diseases in China reported through different channels,and the experts in all provincial centers for disease control and prevention attended this video conference.Results It is estimated that public health emergency event reports in March 2022 will be more than in February 2022.Due to the imported cases persist,the risk of COVID-19 outbreak and spread in China is still high,China faces greater pressure in fighting COVID-19,especially during Winter Olympic Games and two sessions.Each part of China should strictly implement epidemic control and prevention measures to contain the spread of COVID-19.According to the reports of norovirus disease,brucellosis,and severe fever with thrombocytopenia syndrome(SFTS)in previous years,the estimated incidence rates may still high in March.Conclusion Special attention should be paid to COVID-19.General attentions should be paid to norovirus disease,brucellosis,and SFTS.
作者
孔庆福
冯晔囡
靳淼
李建东
刘倩倩
朴东日
孟玲
魏依侬
涂文校
Kong Qingfu;Feng Yenan;Jin Miao;Li Jiandong;Liu Qianqian;Piao Dongri;Meng Ling;Wei Yinong;Tu Wenxiao(Public Health Emergency Center,Chinese Center for Disease Control and Prevention,Beijing 102206,China;National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China;National Immunization Programme,Chinese Center for Disease Control and Prevention,Beijing 100050,China;National Institute for Communicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China)
出处
《疾病监测》
CAS
CSCD
北大核心
2022年第3期293-296,共4页
Disease Surveillance
